Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer

12 december 2016 bijgewerkt door: Alliance for Clinical Trials in Oncology

Parallel Phase II Trials of ZD1839 (Iressa) Alone or Weekly Carboplatin and Paclitaxel Followed by ZD1839 (Iressa) (Oncologists Must Choose) for Metastatic Non-Small Cell Lung Cancer in Patients > or = 65 Years of Age

RATIONALE: Biological therapies such as gefitinib may interfere with the growth of cancer cells and slow the growth of the tumor. Drugs used in chemotherapy such as carboplatin and paclitaxel use different ways to stop tumor cells from dividing so they stop growing or die. Combining gefitinib with carboplatin and paclitaxel may kill more tumor cells.

PURPOSE: This phase II trial is studying how well giving gefitinib alone or together with carboplatin and paclitaxel works in treating older patients with unresectable or metastatic non-small cell lung cancer.

Studie Overzicht

Toestand

Voltooid

Conditie

Interventie / Behandeling

Gedetailleerde beschrijving

OBJECTIVES:

Primary

  • Determine the 6-month progression status of older patients with unresectable or metastatic non-small cell lung cancer treated with gefitinib alone or with carboplatin and paclitaxel.

Secondary

  • Determine the response rate in patients treated with these regimens.
  • Determine the quality of life of patients treated with these regimens.
  • Determine whether serum-secreted or soluble epidermal growth factor receptor (EGFR) concentrations predict response in patients treated with these regimens.
  • Correlate the presence of social support for these patients with toxicity and efficacy of these regimens.
  • Determine whether social support for these patients differs according to gender.
  • Determine the reasons an oncologist would choose a chemotherapy vs a nonchemotherapy regimen for these patients.

Tertiary

  • Correlate EGFR signaling pathway markers, RNA expression profile, gene polymorphisms of prespecified germline and tumor genes, and plasma and urine proteomic patterns with response rate and time to progression of patients receiving treatment in group I.

OUTLINE: This is a nonrandomized, multicenter study. Patients are assigned to 1 of 2 treatment groups as determined by their treating physician.

  • Group I: Patients receive oral gefitinib on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
  • Group II: Patients receive paclitaxel IV over 1 hour and carboplatin IV over 30 minutes on days 1, 8, and 15. Treatment repeats every 28 days for up to 4 courses in the absence of disease progression or unacceptable toxicity. After completion of chemotherapy and in the absence of disease progression, patients receive oral gefitinib as in group I.

Quality of life is assessed at baseline and after the completion of course 2.

Patients are followed every 3 months for 5 years.

PROJECTED ACCRUAL: A total of 107 patients (51 for group I and 56 for group II) will be accrued for this study within 1.7 years.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

65

Fase

  • Fase 2

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

  • Canada
    • Saskatchewan
      • Regina, Saskatchewan, Canada, S4T 7T1
        • Allan Blair Cancer Centre at Pasqua Hospital
  • Verenigde Staten
    • Arizona
      • Scottsdale, Arizona, Verenigde Staten, 85259
        • Mayo Clinic Scottsdale
    • Colorado
      • Fort Collins, Colorado, Verenigde Staten, 80524
        • Front Range Cancer Specialists
    • Florida
      • Jacksonville, Florida, Verenigde Staten, 32224
        • Mayo Clinic - Jacksonville
    • Illinois
      • Aurora, Illinois, Verenigde Staten, 60507
        • Rush-Copley Cancer Care Center
      • Bloomington, Illinois, Verenigde Staten, 61701
        • St. Joseph Medical Center
      • Canton, Illinois, Verenigde Staten, 61520
        • Graham Hospital
      • Carthage, Illinois, Verenigde Staten, 62321
        • Memorial Hospital
      • Effingham, Illinois, Verenigde Staten, 62401
        • St. Anthony's Memorial Hospital
      • Eureka, Illinois, Verenigde Staten, 61530
        • Eureka Community Hospital
      • Galesburg, Illinois, Verenigde Staten, 61401
        • Galesburg Cottage Hospital
      • Galesburg, Illinois, Verenigde Staten, 61401
        • Galesburg Clinic
      • Havana, Illinois, Verenigde Staten, 62644
        • Mason District Hospital
      • Hopedale, Illinois, Verenigde Staten, 61747
        • Hopedale Medical Complex
      • Joliet, Illinois, Verenigde Staten, 60435
        • Joliet Oncology Hematology Associates, Limited - West
      • Kewanee, Illinois, Verenigde Staten, 61443
        • Kewanee Hospital
      • Macomb, Illinois, Verenigde Staten, 61455
        • Mcdonough District Hospital
      • Normal, Illinois, Verenigde Staten, 61761
        • Bromenn Regional Medical Center
      • Normal, Illinois, Verenigde Staten, 61761
        • Community Cancer Center
      • Ottawa, Illinois, Verenigde Staten, 61350
        • Community Hospital of Ottawa
      • Ottawa, Illinois, Verenigde Staten, 61350
        • Oncology Hematology Associates of Central Illinois - Ottawa
      • Pekin, Illinois, Verenigde Staten, 61554
        • Cancer Treatment Center at Pekin Hospital
      • Peoria, Illinois, Verenigde Staten, 61636
        • Methodist Medical Center of Illinois
      • Peoria, Illinois, Verenigde Staten, 61614
        • Proctor Hospital
      • Peoria, Illinois, Verenigde Staten, 61637
        • OSF St. Francis Medical Center
      • Peoria, Illinois, Verenigde Staten, 61615
        • CCOP - Illinois Oncology Research Association
      • Peoria, Illinois, Verenigde Staten, 61615
        • Oncology/Hematology Associates of Central Illinois, P.C.
      • Peru, Illinois, Verenigde Staten, 61354
        • Illinois Valley Community Hospital
      • Princeton, Illinois, Verenigde Staten, 61356
        • Perry Memorial Hospital
      • Spring Valley, Illinois, Verenigde Staten, 61362
        • St. Margaret's Hospital
      • Urbana, Illinois, Verenigde Staten, 61801
        • Carle Cancer Center at Carle Foundation Hospital
      • Urbana, Illinois, Verenigde Staten, 61801
        • CCOP - Carle Cancer Center
    • Indiana
      • Beech Grove, Indiana, Verenigde Staten, 46107
        • St. Francis Hospital and Health Centers - Beech Grove Campus
      • Michigan City, Indiana, Verenigde Staten, 46360
        • Saint Anthony Memorial Health Centers
    • Iowa
      • Cedar Rapids, Iowa, Verenigde Staten, 52402
        • St. Luke's Hospital
      • Cedar Rapids, Iowa, Verenigde Staten, 52403
        • Cedar Rapids Oncology Associates
      • Cedar Rapids, Iowa, Verenigde Staten, 52403
        • Mercy Regional Cancer Center at Mercy Medical Center
      • Des Moines, Iowa, Verenigde Staten, 50309
        • CCOP - Iowa Oncology Research Association
      • Des Moines, Iowa, Verenigde Staten, 50309
        • John Stoddard Cancer Center at Iowa Methodist Medical Center
      • Des Moines, Iowa, Verenigde Staten, 50309
        • Medical Oncology and Hematology Associates at John Stoddard Cancer Center
      • Des Moines, Iowa, Verenigde Staten, 50314
        • Medical Oncology and Hematology Associates at Mercy Cancer Center
      • Des Moines, Iowa, Verenigde Staten, 50314
        • Mercy Cancer Center at Mercy Medical Center - Des Moines
      • Des Moines, Iowa, Verenigde Staten, 50307
        • Mercy Capitol Hospital
      • Des Moines, Iowa, Verenigde Staten, 50316-2301
        • John Stoddard Cancer Center at Iowa Lutheran Hospital
      • Sioux City, Iowa, Verenigde Staten, 51101
        • Siouxland Regional Cancer Center
      • Sioux City, Iowa, Verenigde Staten, 51104
        • St. Luke's Regional Medical Center
      • Sioux City, Iowa, Verenigde Staten, 51104
        • Mercy Medical Center - Sioux City
      • Sioux City, Iowa, Verenigde Staten, 51101
        • Siouxland Hematology-Oncology Associates at June E. Nylen Cancer Center
      • West Des Moines, Iowa, Verenigde Staten, 50266
        • Medical Oncology and Hematology Associates - West Des Moines
    • Kansas
      • Chanute, Kansas, Verenigde Staten, 66720
        • Cancer Center of Kansas, P.A. - Chanute
      • Dodge City, Kansas, Verenigde Staten, 67801
        • Cancer Center of Kansas, P.A. - Dodge City
      • El Dorado, Kansas, Verenigde Staten, 67042
        • Cancer Center of Kansas, P.A. - El Dorado
      • Kingman, Kansas, Verenigde Staten, 67068
        • Cancer Center of Kansas, P.A. - Kingman
      • Liberal, Kansas, Verenigde Staten, 67901
        • Southwest Medical Center
      • Newton, Kansas, Verenigde Staten, 67114
        • Cancer Center of Kansas, P.A. - Newton
      • Parsons, Kansas, Verenigde Staten, 67357
        • Cancer Center of Kansas, P.A. - Parsons
      • Pratt, Kansas, Verenigde Staten, 67124
        • Cancer Center of Kansas, P.A. - Pratt
      • Salina, Kansas, Verenigde Staten, 67042
        • Cancer Center of Kansas, P.A. - Salina
      • Wellington, Kansas, Verenigde Staten, 67152
        • Cancer Center of Kansas, P.A. - Wellington
      • Wichita, Kansas, Verenigde Staten, 67214
        • CCOP - Wichita
      • Wichita, Kansas, Verenigde Staten, 67214
        • Via Christi Cancer Center at Via Christi Regional Medical Center
      • Wichita, Kansas, Verenigde Staten, 67214
        • Cancer Center of Kansas, P.A. - Wichita
      • Wichita, Kansas, Verenigde Staten, 67203
        • Associates in Womens Health, P.A. - North Review
      • Wichita, Kansas, Verenigde Staten, 67208
        • Cancer Center of Kansas, P.A. - Medical Arts Tower
      • Winfield, Kansas, Verenigde Staten, 67156
        • Cancer Center of Kansas, P.A. - Winfield
    • Michigan
      • Adrian, Michigan, Verenigde Staten, 49221
        • Hickman Cancer Center at Bixby Medical Center
      • Lambertville, Michigan, Verenigde Staten, 48144
        • Haematology-Oncology Associates of Ohio and Michigan, P.C.
      • Monroe, Michigan, Verenigde Staten, 48162
        • Community Cancer Center of Monroe
      • Monroe, Michigan, Verenigde Staten, 48162
        • Mercy Memorial Hospital System
    • Minnesota
      • Alexandria, Minnesota, Verenigde Staten, 56308
      • Bemidji, Minnesota, Verenigde Staten, 56601
        • MeritCare Clinic - Bemidji
      • Brainerd, Minnesota, Verenigde Staten, 56401
        • Brainerd Medical Center
      • Brainerd, Minnesota, Verenigde Staten, 56401
        • St. Joseph's Medical Center
      • Burnsville, Minnesota, Verenigde Staten, 55337
        • Fairview Ridges Hospital
      • Coon Rapids, Minnesota, Verenigde Staten, 55433
        • Mercy and Unity Cancer Center at Mercy Hospital
      • Edina, Minnesota, Verenigde Staten, 55435
        • Fairview Southdale Hospital
      • Fergus Falls, Minnesota, Verenigde Staten, 56537
      • Fridley, Minnesota, Verenigde Staten, 55432
        • Mercy and Unity Cancer Center at Unity Hospital
      • Hutchinson, Minnesota, Verenigde Staten, 55350
        • Hutchinson Area Health Care
      • Lichfield, Minnesota, Verenigde Staten, 55355
        • Meeker County Memorial Hospital
      • Maplewood, Minnesota, Verenigde Staten, 55109
        • St. John's Hospital
      • Minneapolis, Minnesota, Verenigde Staten, 55415
        • Hennepin County Medical Center - Minneapolis
      • Minneapolis, Minnesota, Verenigde Staten, 55407
        • Virginia Piper Cancer Institute at Abbott-Northwestern Hospital
      • Montevideo, Minnesota, Verenigde Staten, 56265
        • Chippewa County - Montevideo Hospital
      • Robbinsdale, Minnesota, Verenigde Staten, 55422-2900
        • Hubert H. Humphrey Cancer Center at North Memorial Medical Center
      • Rochester, Minnesota, Verenigde Staten, 55905
        • Mayo Clinic Cancer Center
      • Saint Cloud, Minnesota, Verenigde Staten, 56303
        • Coborn Cancer Center
      • Saint Louis Park, Minnesota, Verenigde Staten, 55416
        • CCOP - Metro-Minnesota
      • Shakopee, Minnesota, Verenigde Staten, 55379
        • Saint Francis Cancer Center
      • St Paul, Minnesota, Verenigde Staten, 55102
        • St. Joseph's Hospital
      • St. Cloud, Minnesota, Verenigde Staten, 56303
        • CentraCare Clinic - River Campus
      • St. Louis Park, Minnesota, Verenigde Staten, 55416
        • Park Nicollet Health Services
      • St. Paul, Minnesota, Verenigde Staten, 55102
        • United Hospital
      • St. Paul, Minnesota, Verenigde Staten, 55101
        • Regions Hospital Cancer Care Center
      • Waconia, Minnesota, Verenigde Staten, 55387
        • Ridgeview Medical Center
      • Woodbury, Minnesota, Verenigde Staten, 55125
        • Woodwinds Health Campus
    • North Dakota
      • Bismarck, North Dakota, Verenigde Staten, 58501
        • Bismarck Cancer Center
      • Bismarck, North Dakota, Verenigde Staten, 58501
        • Cancer Care Center at Medcenter One Hospital
      • Bismarck, North Dakota, Verenigde Staten, 58501
        • Mid Dakota Clinic, P. C.
      • Bismarck, North Dakota, Verenigde Staten, 58502
        • St. Alexius Medical Center
      • Fargo, North Dakota, Verenigde Staten, 58122
        • CCOP - MeritCare Hospital
      • Fargo, North Dakota, Verenigde Staten, 58122
        • MeritCare Medical Group
      • Grand Forks, North Dakota, Verenigde Staten, 58201
        • Altru Cancer Center at Altru Hospital
    • Ohio
      • Bowling Green, Ohio, Verenigde Staten, 43402
        • Wood County Oncology Center
      • Dayton, Ohio, Verenigde Staten, 45428
        • Veterans Affairs Medical Center - Dayton
      • Dayton, Ohio, Verenigde Staten, 45405
        • Grandview Hospital
      • Dayton, Ohio, Verenigde Staten, 45406
        • Good Samaritan Hospital
      • Dayton, Ohio, Verenigde Staten, 45409
        • David L. Rike Cancer Center at Miami Valley Hospital
      • Dayton, Ohio, Verenigde Staten, 45415
        • Samaritan North Cancer Care Center
      • Dayton, Ohio, Verenigde Staten, 45429
        • CCOP - Dayton
      • Findlay, Ohio, Verenigde Staten, 45840
        • Blanchard Valley Medical Associates
      • Fremont, Ohio, Verenigde Staten, 43420
        • Fremont Memorial Hospital
      • Kenton, Ohio, Verenigde Staten, 43326
        • Kenton Oncology, Incorporated
      • Kettering, Ohio, Verenigde Staten, 45429
        • Charles F. Kettering Memorial Hospital
      • Lima, Ohio, Verenigde Staten, 45804
        • Lima Memorial Hospital
      • Maumee, Ohio, Verenigde Staten, 43537
        • Northwest Ohio Oncology Center
      • Maumee, Ohio, Verenigde Staten, 43537
        • St. Luke's Hospital
      • Middletown, Ohio, Verenigde Staten, 45044
        • Middletown Regional Hospital
      • Oregon, Ohio, Verenigde Staten, 43616
        • St. Charles Mercy Hospital
      • Oregon, Ohio, Verenigde Staten, 43616
        • Toledo Clinic - Oregon
      • Sandusky, Ohio, Verenigde Staten, 44870
        • Firelands Regional Medical Center
      • Sandusky, Ohio, Verenigde Staten, 44870
        • North Coast Cancer Care, Incorporated
      • Sylvania, Ohio, Verenigde Staten, 43560
        • Promedica Cancer Center at Flower Hospital
      • Tiffin, Ohio, Verenigde Staten, 44883
        • Mercy Hospital of Tiffin
      • Toledo, Ohio, Verenigde Staten, 43608
        • St. Vincent Mercy Medical Center
      • Toledo, Ohio, Verenigde Staten, 43606
        • Toledo Hospital
      • Toledo, Ohio, Verenigde Staten, 43623
        • Toledo Clinic, Incorporated - Main Clinic
      • Toledo, Ohio, Verenigde Staten, 43623
        • CCOP - Toledo Community Hospital
      • Toledo, Ohio, Verenigde Staten, 43614
        • Medical College of Ohio Cancer Institute
      • Toledo, Ohio, Verenigde Staten, 43623
        • Toledo Surgical Specialists
      • Troy, Ohio, Verenigde Staten, 45373-1300
        • UVMC Cancer Care Center at Upper Valley Medical Center
      • Wauseon, Ohio, Verenigde Staten, 43567
        • Fulton County Health Center
      • Xenia, Ohio, Verenigde Staten, 45385
        • Ruth G. McMillan Cancer Center at Greene Memorial Hospital
    • Pennsylvania
      • Allentown, Pennsylvania, Verenigde Staten, 18105
        • Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
      • Danville, Pennsylvania, Verenigde Staten, 17822-0001
        • Geisinger Medical Center
      • State College, Pennsylvania, Verenigde Staten, 16801
        • Geisinger Medical Group
      • Wilkes-Barre, Pennsylvania, Verenigde Staten, 18711
        • Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
    • South Dakota
      • Sioux Falls, South Dakota, Verenigde Staten, 57117-5039
        • Sioux Valley Hospital and University of South Dakota Medical Center
      • Sioux Falls, South Dakota, Verenigde Staten, 57105-1080
        • Avera McKennan Hospital and University Health Center
      • Sioux Falls, South Dakota, Verenigde Staten, 57105
        • Medical X-Ray Center, P. C.
    • Wisconsin
      • La Crosse, Wisconsin, Verenigde Staten, 54601
        • Franciscan Skemp Healthcare

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

65 jaar tot 120 jaar (Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

DISEASE CHARACTERISTICS:

  • Histologically or cytologically confirmed non-small cell lung cancer (NSCLC)

    • Metastatic or unresectable disease

  • Measurable disease

    • At least 1 lesion at least 2.0 cm
    • Disease must be completely outside prior radiotherapy port OR documented disease progression since the completion of radiotherapy
  • No meningeal carcinomatosis

  • No untreated brain metastases

    • Current metastatic CNS disease must have been treated and clinically stable for at least 2 weeks prior to study chemotherapy
  • No potentially curative treatment options available (e.g., chemotherapy with surgery or radiotherapy)

PATIENT CHARACTERISTICS:

Age

  • 65 and over

Performance status

  • ECOG 0-2

Life expectancy

  • At least 12 weeks

Hematopoietic

  • Absolute neutrophil count at least 1,500/mm^3
  • Platelet count at least 100,000/mm^3
  • Hemoglobin at least 10.0 g/dL

Hepatic

  • Bilirubin no greater than 2.0 mg/dL
  • No uncontrolled hepatic disease

Renal

  • Creatinine no greater than 2 times upper limit of normal
  • No uncontrolled renal disease

Cardiovascular

  • No uncontrolled cardiac disease

Pulmonary

  • No clinically active interstitial lung disease

    • Asymptomatic, chronic stable radiographic changes allowed
  • No uncontrolled respiratory disease

Other

  • Fertile patients must use effective contraception
  • Able and willing to complete questionnaires alone or with assistance
  • No known hypersensitivity to gefitinib or any of its excipients
  • No active infection within the past 2 weeks
  • No other prior malignancy within the past 5 years except basal cell skin cancer
  • No grade 2 or greater peripheral neuropathy (CTC v2.0)
  • No uncontrolled diabetes mellitus (for patients receiving study chemotherapy)
  • No dysphagia or inability to swallow intact capsules
  • No significant medical condition that would preclude study treatment or follow-up
  • No severe or uncontrolled systemic disease

PRIOR CONCURRENT THERAPY:

Biologic therapy

  • Not specified

Chemotherapy

  • See Disease Characteristics
  • No prior chemotherapy for metastatic NSCLC

Endocrine therapy

  • Concurrent steroids allowed provided the dose is not changed

Radiotherapy

  • See Disease Characteristics
  • At least 3 weeks since prior radiotherapy and recovered
  • No prior radiotherapy to more than 25% of marrow-containing skeleton
  • No concurrent radiotherapy (including palliative)

Surgery

  • See Disease Characteristics
  • At least 3 weeks since prior major surgery
  • No surgery within 7 days after study participation

Other

  • More than 30 days since prior non-FDA approved investigational drugs
  • No concurrent oral retinoids

  • No concurrent CYP3A4-inducing agents, including the following:

    • Carbamazepine
    • Oxcarbazepine
    • Modafinil
    • Ethosuximide
    • Griseofulvin
    • Nafcillin
    • Phenobarbital
    • Phenylbutazone
    • Phenytoin
    • Primidone
    • Rifampin
    • Hypericum perforatum (St. John's wort)
    • Barbiturates
    • Sulfinpyrazone
  • No concurrent drugs that cause sustained elevation of gastric pH (≥ 5)
  • No concurrent antacids within 4 hours before, during, and within 4 hours after gefitinib administration
  • No concurrent itraconazole, fluconazole, ketoconazole, or erythromycin

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Niet-gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: gefitinib

Patients receive oral gefitinib on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.

Quality of life is assessed at baseline and after the completion of course 2.

Patients are followed every 3 months for 5 years.
Geneesmiddel: gefitinib
Experimenteel: paclitaxel + carboplatin + gefitinib

Patients receive paclitaxel IV over 1 hour and carboplatin IV over 30 minutes on days 1, 8, and 15. Treatment repeats every 28 days for up to 4 courses in the absence of disease progression or unacceptable toxicity. After completion of chemotherapy and in the absence of disease progression, patients receive oral gefitinib as in group I.

Quality of life is assessed at baseline and after the completion of course 2.

Patients are followed every 3 months for 5 years.
Geneesmiddel: carboplatine
Geneesmiddel: paclitaxel
Geneesmiddel: gefitinib

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Tijdsspanne
Progression status at 6 months
Tijdsspanne: at 6 months
at 6 months

Secundaire uitkomstmaten

Uitkomstmaat
Tijdsspanne
Progressievrije overleving
Tijdsspanne: Tot 5 jaar
Tot 5 jaar
Algemeen overleven
Tijdsspanne: Tot 5 jaar
Tot 5 jaar
Confirmed response rate (complete or partial response)
Tijdsspanne: Up to 5 years
Up to 5 years
Quality of life as assessed by the Lung Cancer Symptom scale
Tijdsspanne: Up to 5 years
Up to 5 years
Social support measure as assessed by the Lubben Social Network scale
Tijdsspanne: Up to 5 years
Up to 5 years

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Alliance for Clinical Trials in Oncology

Medewerkers

National Cancer Institute (NCI)

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start

1 oktober 2004

Primaire voltooiing (Werkelijk)

1 augustus 2006

Studie voltooiing (Werkelijk)

1 november 2010

Studieregistratiedata

Eerst ingediend

5 juni 2003

Eerst ingediend dat voldeed aan de QC-criteria

5 juni 2003

Eerst geplaatst (Schatting)

6 juni 2003

Updates van studierecords

Laatste update geplaatst (Schatting)

14 december 2016

Laatste update ingediend die voldeed aan QC-criteria

12 december 2016

Laatst geverifieerd

1 december 2016

Meer informatie

Termen gerelateerd aan deze studie

Trefwoorden

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • NCCTG-N0222
  • NCI-2012-02535 (Register-ID: CTRP (Clinical Trials Reporting System))
  • CDR0000304453 (Register-ID: PDQ (Physician Data Query))

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren